Everyone knows what a first aid kit is. We’ve all seen them. We’ve all used them. Convenient boxes containing the basic tools needed to treat medical emergencies: bandages and antibiotic ointments for cuts, cold compresses for burns, aspirin for headaches and inflammation.
But what if someone were to have a psychiatric emergency? Would others even know it was happening? Would anyone know what to do? Are there ‘tools’ to help someone in psychiatric distress?
With the arrival of March, the country’s sports-watching public made its annual pivot from the Super Bowl to the student athletes across the nation vying to win the NCAA men’s basketball tournament. “March Madness”, as it is known colloquially, is a beloved sporting event – marked by students’ passion for their team in pursuit of its “one shining moment”.
The students’ excitement we see on vivid display at the tournament games belies the hardship many of them endure as they struggle with untreated or under-treated mental illnesses.
The room was packed at the Primary Care Development Corporation’s (PCDC)* Primary Care Innovation Circle.
More than 200 health care executives, providers, community-based agency leaders and practitioners assembled to listen to panelists address the most audacious of tasks: the fate of health care in the United States.
While most people are slowly emerging from the holiday haze, the healthcare investment community kicks off January with the J.P. Morgan Healthcare Conference.
Originally an investors’ meeting for select public and private healthcare companies, the event – and the ecosystem of smaller conferences that surround it – now bring an estimated 30,000 people to San Francisco.
Emergency Department (ED) “boarding” – when patients get stuck in the ED for hours, sometimes days, because there is no placement option readily available – is an issue across the country and has received much attention in Massachusetts recently.
Earlier this month, The Boston Globe published an article highlighting the fact that many of these individuals have behavioral health conditions.
As a professional observer of healthcare for the last 20 years, the relationship between Adam Smith economics and healthcare research and developments has always fascinated me.
In brief, does the dynamic of competition that drives profit-making innovation propel, or hinder, medical breakthroughs?
The National Institutes of Health (NIH) initiative around “precision medicine” – treatment that focuses on the unique genetic code of the individual and not a one-size-fits-all treatment – begs that question.
So often when we speak about mental illness and substance use disorders, we talk about numbers: the number of people who have died from overdoses; the number of people who take antidepressants; the cost of mental health to society at large.
However, at the Kennedy Forum Illinois in December, keynote speakers put a face and soul to addiction.
Almost a century has passed, but these words continue to ring true and speak to our current tragic opiate crisis.
This crisis has touched almost everyone I have met and has spared no demographic group. The silver lining in this cloudy sky is the mobilization and alignment of legislators, medical professionals, the public and the insurance industry on wiping out this epidemic. Fortunately, changes have occurred rapidly that foretell a positive direction.